Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Myelography × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoldering Multiple Myeloma 1

Interventions

Radiotherapy 270 Cisplatin 246 Cyclophosphamide 201 Doxorubicin 157 Paclitaxel 156 Carboplatin 141 Vincristine 138 Etoposide 123 Filgrastim 121 Fluorouracil 106 Gemcitabine 104 Docetaxel 102 Dexamethasone 94 Methotrexate 92 Cytarabine 91 Leucovorin 80 Prednisone 78 Gene Expression Profiling 74 Granulocyte Colony-Stimulating Factor 65 Capecitabine 58 Irinotecan 55 Specimen Handling 53 Magnetic Resonance Spectroscopy 51 Ifosfamide 49 Radiation 48 Oxaliplatin 47 Polymerase Chain Reaction 46 Immunohistochemistry 45 Temozolomide 44 Radiotherapy, Conformal 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04144387 2024-03-06

CARRISMM

Intergroupe Francophone du Myelome

Phase NA Active not recruiting

Smoldering Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡